Literature DB >> 6991084

Modified Christie-Atkins-Munch-Petersen (CAMP) test for direct identification of hemolytic and nonhemolytic group B streptococci on primary plating.

B H Bae, E J Bottone.   

Abstract

A primary plating medium, using sheep blood agar with preformed zones of cell-free staphylococcal beta-hemolysin, was used for direct identification of both hemolytic and nonhemolytic group B streptococci by the direct elicitation of the Christie-Atkins-Munch-Petersen (CAMP) reaction. A positive CAMP reaction consisted of a semilunar-shaped area or circle of complete hemolysis of sheep erythrocytes and occurred only when colonies of group B streptococci developed along the periphery of the preformed zone of staphylococcal beta-hemolysin. Of 104 simulated specimens containing group B streptococci in combination with a variety of microbial species and of 85 vaginal specimens examined, direct recognition of group B streptococci was possible in 64 (61.5%) simulated specimens and in 12 (100%) vaginal cultures. Group B streptococcal colonies not developing along the active edge of staphylococcal beta-hemolysin were still identified by subculture. Of particular value was the facilitated recognition of colonies of nonhemolytic group B streptococcal strains and of hemolytic group B streptococci few in number or overgrown by other microbial species.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991084     DOI: 10.1139/m80-091

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  2 in total

1.  Corynebacterium aquaticum urinary tract infection in a neonate, and concepts regarding the role of the organism as a neonatal pathogen.

Authors:  C Tendler; E J Bottone
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

2.  Method for quantitative detection and presumptive identification of group B streptococci on primary plating.

Authors:  Søren Mose Hansen; Uffe B Skov Sørensen
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.